<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T21:42:46Z</responseDate><request verb="GetRecord" identifier="oai:digital.lib.washington.edu:1773/51992" metadataPrefix="dim">https://digital.lib.washington.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:digital.lib.washington.edu:1773/51992</identifier><datestamp>2026-02-15T22:45:05Z</datestamp><setSpec>com_1773_4888</setSpec><setSpec>col_1773_4918</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Kukull, Walter A</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Yasuda, Sarah Mamiko</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2024-09-09T23:08:44Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2024-09-09</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2024</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">Yasuda_washington_0250O_26896.pdf</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1773/51992</dim:field>
   <dim:field mdschema="dc" element="description">Thesis (Master's)--University of Washington, 2024</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Introduction: Dementia affects millions of Americans with symptoms such as impaired ability to recall, reason, or make decisions. While Alzheimer’s Disease (AD) accounts for most 
dementia cases, multiple neuropathologic features often coexist, complicating diagnosis and 
treatment. Recent studies have revealed the complexity of neuropathology with the majority of
participants exhibiting multiple neuropathologic features, emphasizing the need for a thorough 
understanding of the association between individual and combinations of neuropathologic 
features on cognitive performance. This study aims to examine the individual and combined 
effects of Alzheimer’s disease neuropathologic change (ADNC), Lewy body disease (LBD), 
vascular brain injury (VBI), and limbic predominant, age related, TDP-43 encephalopathy 
(LATE) on cognitive performance. 
Methods: This study used longitudinal clinical visit data and autopsy results from 880 
participants from the National Alzheimer's Coordinating Center (NACC) Uniform Data Set 
(UDS). A linear mixed effects model was used to investigate the effects of neuropathologic 
features on cognitive performance across four domains: episodic memory, attention/working 
memory, semantic memory/language, and executive function. Additionally, interactions between 
two neuropathologic features were analyzed to determine whether there is an additive effect on 
cognitive decline.
Results: The rate of decline in overall cognitive performance was fastest among participants in the 
ADNC + LATE category (-0.46, 95% CI: -0.52, -0.41). The ADNC + LBD category had the fastest 
decline for attention/working memory (-0.11, CI: -0.14, -0.08), semantic memory/language (-0.19, CI: -
0.22, -0.15), and executive function domains (-0.25, CI: -0.30, -0.21). For the episodic memory domain, 
the fastest decline was seen in the LATE-only category (-0.08, CI: -0.11, -0.06). Less than additive effect 
was seen for most interactions between two neuropathologic features. The less than additive interaction
between ADNC + VBI were all statistically significant across domains, along with ADNC + LATE for 
episodic memory.
Discussion: Overall, the annual change in z-scores was generally greater for categories with multiple 
neuropathologic features compared to those with a single feature alone. Among the single 
neuropathologic features, ADNC had the greatest annual change in all domains except episodic memory, 
suggesting that ADNC contributes more to cognitive decline than the other neuropathologic features. The 
variety in trends across domains may also indicate that the effect of neuropathologic features on cognitive 
performance differ between cognitive domains. The analysis of interactions between ADNC and LBD, 
VBI, and LATE revealed that most combinations had a slower rate of decline than what would be 
expected if each neuropathologic feature contributed independently in an additive model. This indicates 
that the combined effects of these pathologies are not merely additive but involve more complex 
interactions. The findings highlight the complexity of analyzing the additive effects and their differential 
impacts on various cognitive domains. Given that the interactions vary between studies, it is crucial to 
consider multiple neuropathologic features when assessing cognitive decline and dementia.</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en_US</dim:field>
   <dim:field mdschema="dc" element="rights">none</dim:field>
   <dim:field mdschema="dc" element="subject">Alzheimer's Disease</dim:field>
   <dim:field mdschema="dc" element="subject">Dementia</dim:field>
   <dim:field mdschema="dc" element="subject">Lewy body</dim:field>
   <dim:field mdschema="dc" element="subject">Limbic predominant age-related TDP-43 encephalopathy</dim:field>
   <dim:field mdschema="dc" element="subject">Vascular brain injury</dim:field>
   <dim:field mdschema="dc" element="subject">Public health</dim:field>
   <dim:field mdschema="dc" element="subject" qualifier="other">Epidemiology</dim:field>
   <dim:field mdschema="dc" element="title">Effects of Multiple Neuropathologic Features and Their Interactions on Cognitive Performance</dim:field>
   <dim:field mdschema="dc" element="type">Thesis</dim:field>
   <dim:field mdschema="dc" element="embargo" qualifier="terms">Restrict to UW for 2 years -- then make Open Access</dim:field>
   <dim:field mdschema="dc" element="embargo" qualifier="lift">2026-08-30T23:08:44Z</dim:field>
   <dim:field mdschema="others" element="access-status">embargo</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>